The importance of quantifying skin reactivity in treating allergic rhinitis with immunotherapy

Ear, Nose and Throat Journal

Volumn 79, Issue 5, 2000, Pages 362-366

  Trevino, Richard J ^a,c   Veling, Maria C ^b  

^a Louisiana State University Health Sciences Center at Shreveport   (United States)

^b University of Louisville School of Medicine   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4;

ALLERGIC RHINITIS; ANTIGEN ANTIBODY COMPLEX; ARTICLE; DISEASE ASSOCIATION; HELPER CELL; HUMAN; IMMUNITY; IMMUNOREACTIVITY; IMMUNOTHERAPY; PREVALENCE; SKIN ALLERGY; SKIN TEST; SUPPRESSOR CELL;

EID: 0034075036     PISSN: 01455613     EISSN: None     Source Type: Journal    
DOI: 10.1177/014556130007900508     Document Type: Article

References (20)

1. Nathan RA, Meltzer EO, Selner JC, Storms W. Prevalence of allergic rhinitis in the United States. J Allergy Clin Immunol 1997;99(Suppl):S808-S814.
2. Collins JG. Prevalence of selected chronic conditions: United States, 1986-88. Vital and Health Statistics. Hyattsville, Md.: Public Health Service. U.S. Department of Health and Human Services Publication (PHS 93-1510, series 10, No. 182), 1993.
3. U.S. Department of Health and Human Services. Asthma and allergies: An optimistic future. Bethesda. Md.: National Institutes of Health (Publication No. 80-388), 1980.
4. Storms W, Meltzer EO, Nathan RA, Seiner JC. The economic impact of allergic rhinitis. J Allergy Clin Immunol 1997;99 (Suppl):S820-S824.
5. Zeiss CR, Metzger WJ, Levitz D. Quantitative relationships between IgE antibody and blocking antibodies specific for antigen E in patients given immunotherapy with ragweed antigen E. Clin Exp Immunol 1977;28:250-5.
6. Rocklin RE, Sheffer AL, Greineder DK, Melmon KL. Generation of antigen-specific suppressor cells during allergy desensitization. N Engl J Med 1980;302:1213-9.
7. Ohashi Y, Nakai Y, Okamoto H, et al. Significant correlation between symptom score and IgG4 antibody titer following long-term immunotherapy for perennial allergic rhinitis. Ann Otol Rhinol Laryngol 1997;106:483-9.
8. Djurup R, Malling HJ. High IgG4 antibody level is associated with failure of immunotherapy with inhalant allergens. Clin Allergy 1987;17:459-68.
9. In vivo diagnostic testing and immunotherapy for allergy. Report I, Part I, of the allergy panel. Council on Scientific Affairs. JAMA 1987;258:1363-7.
10. Lewis T, Grant RT. Vascular reactions of the skin to injury. Heart 1926;13:219-25.
11. Pepys J, Skin testing. Br J Hosp Med 1975;10(Suppl):1-59.
12. Nelson HS. Diagnostic procedures in allergy. I. Allergy skin testing. Ann Allergy 1983;51:411-8.
13. Pepys J. Skin tests in diagnosis In: Gell PGH, Coombs RRA, Lachmann PJ, eds. Clinical Aspects of Immunology. 3rd ed Oxford: Blackwell Scientific Publications, 1975:55-80.
14. Brown HM, Su S, Thantrey N. Prick testing for allergens standardized by using a precision needle Clin Allergy 1981;11:95-8.
15. Adinoff AD, Rosloniec DM, McCall LL, Nelson HS. A comparison of six epicutaneous devices in the performance of immediate hypersensitivity skin testing. J Allergy Clin Immunol 1989;84: 168-74.
16. Kniker WT. Multi-Test skin testing in allergy: A review of published findings. Ann Allergy 1993;71:485-91.
17. Krouse HA, Klaustermeyer WB. Immediate hypersensitivity skin testing: A comparison of scratch, prick and intradermal techniques. Immunol Allergy Pract 1980;2:94-101.
18. King HC. An Otolaryngologist's Guide to Allergy. New York Thieme Medical Publishers, 1990.
19. Willoughby JW. New concepts in immunotherapy. Otolaryngol Clin North Am 1992;25:71-100.
20. Cook PR. In vivo testing and immunotherapy. Current Opinion in Otolaryngology Head and Neck Surgery 1994;2:118-27.